Compare Expeditors International of Wshngtn Inc (EXPD) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expeditors International of Wshngtn Inc vs Moderna, Inc. — how do they compare? Expeditors International of Wshngtn Inc trades at $177.4 (market cap $23.04B), while Moderna, Inc. trades at $60.81 (market cap $24.18B). The key difference: Expeditors International of Wshngtn Inc and Moderna, Inc. are close in size by market cap, and Expeditors International of Wshngtn Inc pays a 0.91% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| EXPD | MRNA | |
|---|---|---|
Market Cap | $23.04B | $24.18B |
Sector | Industrials | Health |
52-Week High | $182.80 | $81.80 |
52-Week Low | $113.13 | $22.36 |
Enterprise Value | $22.57B | $20.33B |
Dividend Yield | 0.91% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Expeditors International of Wshngtn Inc
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
